IP Library Granted Patent US 11,453,892
Granted Patent B2
US 11,453,892 · App. 15/910,620 · Granted Sep 27, 2022

Crispr-CAS10 systems and methods for phage genome editing

Inventor: Asma Hatoum (Northport, AL)
Assignee: The Board of Trustees of The University of Alabama
C12N15/86C12N1/205C12N9/1276C12N9/22C12N15/11C12N15/74C12N15/902C12N2310/20C12N2710/00042C12N2710/00045C12N2795/10121C12N2795/10221C12N2795/10321C12R2001/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,453,892
App. No.
15/910,620
Granted
Sep 27, 2022
Kind
B2
Abstract

The present disclosure relates to CRISPR-Cas10 systems and methods for phage genome editing.

Claims (11)

1. A phage genome editing system comprising:

a Staphylococcus bacterial cell that can be infected by a phage;

a vector comprising a crRNA that can hybridize to a nucleic acid sequence of the phage; and

a vector comprising a donor nucleic acid sequence, wherein the donor nucleic acid sequence comprises: a mutated nucleic acid sequence to be introduced into the phage, flanked by two nucleic acid sequences containing regions of homology to the phage genome.

2. The system of claim 1 , wherein the Staphylococcus bacterial cell is selected from Staphylococcus epidermidis or Staphylococcus aureus.

3. The system of claim 1 , wherein the Staphylococcus bacterial cell comprises an endogenous CRISPR-Cas10 system.

4. The system of claim 1 , wherein the Staphylococcus bacterial cell has endogenous CRISPR sequences deleted.

5. The system of claim 1 , wherein the phage is a lytic phage.

6. The system of claim 5 , wherein the lytic phage is selected from the group consisting of a Podoviridae phage, a Myoviridae phage, and a Siphoviridae phage.

7. The system of claim 1 , wherein the crRNA and the donor nucleic acid sequence are comprised on the same vector.

8. The system of claim 1 , wherein the mutated nucleic acid sequence is selected from the group consisting of: at least one point mutation, an insertion mutation, and a deletion mutation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2018
From: HATOUM, ASMA
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA
Reel/Frame 046302/0171 →
CONFIRMATORY LICENSE Recorded Apr 12, 2018
From: UNIVERSITY OF ALABAMA IN TUSCALOOSA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045927/0082 →
Continuity (2)
Provisional Application 62465929 · Mar 2, 2017
Related Publication 20180251787A1 · Sep 6, 2018